Robert Liptak
Insider
First SEC filing: Aug. 2, 2012 · Latest: Aug. 2, 2012
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 22, 2019 | GMED | A | 25,000 | · | · | 25,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 22, 2018 | GMED | A | 25,000 | · | · | 25,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 30, 2017 | GMED | A | 25,000 | · | · | 25,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 25, 2016 | GMED | A | 20,000 | · | · | 20,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 6, 2016 | GMED | M | 15,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| Jan. 6, 2016 | GMED | S 10b5-1 | 15,000 | $27.50 | $412,500 | 26,159 Direct | -36.44% | Disposed | 178.4% (price as of 2026-10-05) |
| Jan. 6, 2016 | GMED | M | 15,000 | $15.34 | $230,100 | 41,159 Direct | +57.34% | Acquired | 399.2% (price as of 2026-10-05) |
| Jan. 4, 2016 | GMED | M | 300 | · | · | 15,000 Direct | -1.96% | Disposed | (price as of 2026-10-05) |
| Jan. 4, 2016 | GMED | S 10b5-1 | 300 | $27.50 | $8,250 | 26,159 Direct | -1.13% | Disposed | 178.4% (price as of 2026-10-05) |
| Jan. 4, 2016 | GMED | M | 300 | $15.34 | $4,602 | 26,459 Direct | +1.15% | Acquired | 399.2% (price as of 2026-10-05) |
| Jan. 20, 2015 | GMED | A | 15,000 | · | · | 15,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 23, 2014 | GMED | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Dec. 6, 2013 | GMED | S | 25,000 | $19.36 | $484,000 | 26,159 Direct | -48.87% | Disposed | 295.5% (price as of 2026-10-05) |
| Sept. 3, 2013 | GMED | J | 51,159 | · | · | 51,159 Direct | · | Acquired | (price as of 2026-10-05) |
| Sept. 3, 2013 | GMED | J | 7,244,201 | · | · | 0 Indirect | -100.00% | Disposed | (price as of 2026-10-05) |
| Jan. 30, 2013 | GMED | A | 7,500 | · | · | 7,500 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 29, 2012 | GMED | A | 15,300 | · | · | 15,300 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 8, 2012 | GMED | C | 7,444,168 | · | · | 0 Indirect | -100.00% | Disposed | (price as of 2026-10-05) |
| Aug. 8, 2012 | GMED | S | 804,232 | $11.16 | $8,975,229 | 7,244,201 Indirect | -9.99% | Disposed | 586.1% (price as of 2026-10-05) |
| Aug. 8, 2012 | GMED | C | 7,444,168 | · | · | 8,048,433 Indirect | +1231.94% | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 22, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $43.58 | Jan. 22, 2029 | 25,000 | Acquired |
| Jan. 22, 2018 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $43.77 | Jan. 22, 2028 | 25,000 | Acquired |
| Jan. 30, 2017 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $26.27 | Jan. 30, 2027 | 25,000 | Acquired |
| Jan. 25, 2016 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $25.52 | Jan. 25, 2026 | 20,000 | Acquired |
| Jan. 6, 2016 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $15.34 | Aug. 29, 2022 | 15,000 | Disposed |
| Jan. 4, 2016 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $15.34 | Aug. 29, 2022 | 300 | Disposed |
| Jan. 20, 2015 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $24.10 | Jan. 20, 2025 | 15,000 | Acquired |
| Jan. 23, 2014 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $23.95 | Jan. 23, 2024 | 10,000 | Acquired |
| Jan. 30, 2013 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $12.59 | Jan. 30, 2023 | 7,500 | Acquired |
| Aug. 29, 2012 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $15.34 | Aug. 29, 2022 | 15,300 | Acquired |
| Aug. 8, 2012 | GMED | Series E Preferred Stock | Class A Common Stock | · | · | 7,444,168 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.